Burning Rock Biotech Files 6-K Report
Ticker: BNR · Form: 6-K · Filed: May 29, 2024 · CIK: 1792267
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Burning Rock Biotech filed a 6-K, check Exhibit 99.1 for May updates.
AI Summary
Burning Rock Biotech Ltd. filed a Form 6-K on May 29, 2024, incorporating by reference certain information from Exhibit 99.1. This filing pertains to the month of May 2024 and is for a foreign private issuer. The company is registered with the SEC under file number 001-39316.
Why It Matters
This filing provides updated information to investors regarding Burning Rock Biotech's activities and financial reporting for the period ending May 2024.
Risk Assessment
Risk Level: low — A 6-K filing is a routine report for foreign private issuers and typically contains updates or information that doesn't represent a significant new event.
Key Players & Entities
- Burning Rock Biotech Ltd (company) — Registrant
- 001-39316 (company) — SEC File Number
- 20240529 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What specific information is being incorporated by reference in this filing?
Exhibit 99.1 of this current report on Form 6-K is incorporated by reference, excluding paragraphs under 'Non-GAAP Measures', the table under 'Burning Rock Biotech Limited Reconciliations of GAAP and Non-GAAP Results', and other discussions on non-GAAP measures.
What is the filing date and period of report for this 6-K?
The filing date and the period of report for this 6-K is May 29, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
Does Burning Rock Biotech file annual reports under Form 20-F or 40-F?
Burning Rock Biotech indicates that it files annual reports under Form 20-F.
Filing Stats: 219 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-05-29 06:05:27
Filing Documents
- d841385d6k.htm (6-K) — 10KB
- d841385dex991.htm (EX-99.1) — 178KB
- g841385g30d80.jpg (GRAPHIC) — 23KB
- 0001193125-24-148554.txt ( ) — 220KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Leo Li Name: Leo Li Title: Chief Financial Officer Date: May 29, 2024 4